Biomarkers Predict Response to Palbociclib-Anastrozole Therapy
In an intense and promising leap forward in the fight against breast cancer, researchers have unveiled groundbreaking findings on the ...
Tag: HER2-negative breast cancer
Transcriptomic Insights into Endocrine-Resistant Breast Cancer
In a groundbreaking study published in BMC Cancer, researchers have delved deep into the molecular landscape of endocrine-resistant breast cancer, ...
Gene Panel Predicts Response to Crucial Breast Cancer Therapy
Researchers unveil a groundbreaking immune-based genomic signature that promises to revolutionize treatment strategies for hormone receptor-positive, HER2-negative breast cancer by ...
Italian Study Reveals Breast Cancer Treatment Preferences
In the rapidly evolving landscape of metastatic breast cancer treatment, understanding patient preferences has emerged as a critical component for ...
Capivasertib, Fulvestrant Show Promise in Advanced Breast Cancer
In a groundbreaking development that promises to reshape the therapeutic landscape of advanced breast cancer, a recent study has provided ...
CDK4/6 Inhibitors Boost First-Line Breast Cancer Therapy
In an ambitious stride toward optimizing treatment for hormone receptor-positive (HR+)/HER2-negative advanced breast cancer, a recent comprehensive network meta-analysis has ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!